Aptose Biosciences
Stock Forecast, Prediction & Price Target
Aptose Biosciences Financial Estimates
Aptose Biosciences Revenue Estimates
Aptose Biosciences EBITDA Estimates
Aptose Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $512K Low: $512K High: $512K avg. 0% | Avg: $38.85M Low: $38.85M High: $38.85M avg. 7489.64% | Avg: $5.2M Low: $5.2M High: $5.2M avg. -86.61% | Avg: $6.7M Low: $6.7M High: $6.7M avg. 28.84% |
Net Income
% change YoY
| $-65.26M N/A | $-41.05M 37.09% | $-51.20M -24.73% | Avg: $-14.48M Low: $-14.48M High: $-14.48M avg. 71.70% | Avg: $-4.93M Low: $-4.93M High: $-4.93M avg. 65.96% | Avg: $-3.64M Low: $-3.64M High: $-3.64M avg. 26.02% | Avg: $-2.36M Low: $-2.36M High: $-2.36M avg. 35.18% |
EBITDA
% change YoY
| $-64.82M N/A | $-42.06M 35.10% | $-52.26M -24.25% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$10.99 N/A | -$6.67 39.30% | -$7.58 -13.64% | Avg: -$2.15 Low: -$2.15 High: -$2.15 avg. 71.70% | Avg: -$0.73 Low: -$0.73 High: -$0.73 avg. 65.96% | Avg: -$0.54 Low: -$0.54 High: -$0.54 avg. 26.02% | Avg: -$0.35 Low: -$0.35 High: -$0.35 avg. 35.18% |
Operating Expenses
% change YoY
| $65.44M N/A | $42.60M -34.90% | $52.35M 22.89% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Aptose Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 49.72% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -14.48M, average is -14.48M and high is -14.48M.
What is Aptose Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1857.96% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $512K, average is $512K and high is $512K.
What is Aptose Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 49.72% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.15, average is -$2.15 and high is $-2.14.